Ru Zhou

机构：University of British Columbia · ORCID：0000-0002-3502-9861

发表论文 161 篇 · 总被引 5568 次 · h-index 42

代表论文

• Targeting tumor-associated MUC1 overcomes anoikis-resistance in pancreatic cancer (2022 · Translational research · 被引 96)
• Design and Synthesis of Functionally Active 5-Amino-6-Aryl Pyrrolopyrimidine Inhibitors of Hematopoietic Progenitor Kinase 1 (2023 · Journal of Medicinal Chemistry · 被引 40)
• Functional cRGD-Conjugated Polymer Prodrug for Targeted Drug Delivery to Liver Cancer Cells (2022 · ACS Omega · 被引 24)
• Discovery of PF-07265028, A Selective Small Molecule Inhibitor of Hematopoietic Progenitor Kinase 1 (HPK1) for the Treatment of Cancer (2024 · Journal of Medicinal Chemistry · 被引 23)
• Overexpression of MUC1 Induces Non-Canonical TGF-β Signaling in Pancreatic Ductal Adenocarcinoma (2022 · Frontiers in Cell and Developmental Biology · 被引 22)
• Mucin-1–Targeted Chimeric Antigen Receptor T Cells Are Effective and Safe in Controlling Solid Tumors in Immunocompetent Host (2024 · Journal of Immunotherapy · 被引 15)